bpc-157 clinical trials location Planned by Johns Hopkins Physician | Christopher L. Robinson, MD PhD posted on the topic The Real BPC-157 Story: 544
Description
5-Amino-1MQ is a small molecule that works as an NNMT inhibitor
Cigarette smoking, which seems to contribute to the development and periodic flare-ups of Crohn disease, seems to decrease the risk of ulcerative colitis
Side effects are rare and usually mild, such as slight redness or swelling at the injection site
Clinically Tested Quality Assured Every batch undergoes third-party testing to ensure potency, and consistency
